This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. GENEVA (AP) — Switzerland’s medical products ...

Monoclonal antibodies provide protection against a wide range of infectious microbes, and now, in a series of elegant laboratory experiments, scientists have uncovered how a pair of these ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The logo of Swiss drugmaker Novartis is pictured at the company's French headquarters in Rueil-Malmaison ZURICH ...

A recent study published in The New England Journal of Medicine has revealed that mass administration of ivermectin, a drug long used for treating river blindness and scabies, can significantly reduce ...

This Traverse City doc’s 29 years of research in a humble African medical clinic has saved hundreds of thousands of children’s lives. Dr. Terrie Taylor isn’t done yet, though. At this particular ...

There's no denying the healing power of our local herbs. Malaria is so common in Nigeria, that many of us don’t even flinch when we feel the symptoms—body weakness, fever, chills, and that pounding ...

A new generation of malaria drugs failed clinical trials, in part because they were hard to swallow. UCSF chemists remodeled their structures to make them more soluble, while maintaining their ...

GENEVA (AP) — Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of ...

ZURICH (Reuters) -Novartis said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat malaria in babies and very young children. Eight African ...

GENEVA (AP) — Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of ...